WORLD'S LARGEST MARKET RESEARCH RESOURCE — 1,519,265 REPORTS

 
 
• SEARCH FOR A REPORT

Viewing report

Search
Enter keywords, a title or a report id number below.
Advanced

• ORDER BY FAX

Order By Fax

• SELECT SITE CURRENCY

Select a currency for use throughout the site



  • Site License Information Icon
  • Site License Information Icon
  • Enterprisewide Information Icon
  • Enterprisewide Information Icon
Live Chat Live Help Software for Website

Western European Markets for Peripheral Vascular Stents and AAA Stent-Grafts

Frost & Sullivan, December 2010, Pages: 80

The objective of this research service is to provide detailed analysis of the largely stable European peripheral vascular stents and AAA stent graft market. This service provides an in-depth analysis of the market split into three segments –Aortic and Carotid Interventions, Abdominal Stents and Lower limb stents. The research service discusses revenues, market share analysis and the competitive landscape on a broader view. It also provides strategies for companies involved in the Peripheral vascular stents and stent graft market. Additionally, the research service provides decision support databases related to hospital resources and healthcare expenditure

Research Overview
This Frost & Sullivan research service titled Western European Markets for Peripheral Vascular Stents and AAA Stent-Grafts offers a comprehensive overview of the market including key drivers, restraints and challenges. In this research, Frost & Sullivan's expert analysts thoroughly examine the following markets: aortic and carotid interventions, abdominal stents and lower limb stents.

Market Overview

Innovative Drug-device Combinations Promote Market Advancement

The growing popularity among surgeons for drug-device combination products, coupled with advanced imaging techniques that improve the accuracy of surgical procedures using peripheral vascular stents and AAA stent-grafts, are promoting the adoption of such devices. “The treatment of peripheral arterial disease using drug-device combination products is a new practice,” notes the analyst of this research. “The introduction of peripheral vascular drug eluting stents for the treatment of peripheral arterial disease (PAD) has opened up the market for other participants with novel combinations.”

Developments in imaging technology have improved the accuracy and safety of vascular surgery and implantation, leading to an increase in the number of attempted stenting procedures. Refinement of imaging technology has enabled real-time monitoring of both vascular anatomy and function before and during surgery. Technologies that play a significant role in vascular surgery include computed tomography (CT), ultrasound and angiography.

“The positive outcome of clinical trials is encouraging increased stent use,” states the analyst. “While most industry experts concur that the off-label use of peripheral stents is a widespread practice, especially in the United States, it is important to note that indication specific stents are sought by clinicians and offer growth opportunities for manufacturers.” Currently, several clinical trials are underway to prove the safety, efficacy and merits of both renal and carotid stents. Clinical trials for stents serve dual purposes. They attract attention from clinicians, who will ultimately perform such procedures. Furthermore, if the outcomes of these trials are positive, then physicians, specialists and patients alike will be interested in pursuing stent procedures as a treatment for renal and carotid vascular diseases, thereby increasing the market for stents.

“Offering one-stop-shop solutions, developing long-standing client relationships, fostering extensive distribution channels and investing in R&D will be key competitive factors,” advises the analyst. “Developing local market knowledge, forging flexible collaborative alliances with end users and designing niche products will also be key to success.”

Market Sectors

Expert Frost & Sullivan analysts thoroughly examine the following market segments in this research:
- Aortic and carotid interventions
- Abdominal stents
- Lower limb stents

- 1. Executive Summary
- - Summary of European Peripheral Vascular Stents and AAA Stent Graft Market
- - - Introduction
- - - Major Findings

- 2. Research Methodology
- - Market Engineering Research Methodology and Process
- - - Research Methodology

- 3. Market Dynamics for Peripheral Vascular Stents and AAA Stent-Graft Market
- - Peripheral Vascular Stents and AAA Stent-Graft Market
- - - Market Engineering Measurements
- - - Generations of Stent Technology
- - - Peripheral Vascular Stent and AAA Stent-Graft Market Segmentation
- - - Aortic and Carotid Interventions Market
- - - Abdominal Stents
- - - Lower Limb Stents
- - - Market Drivers for Peripheral Vascular Stents and AAA Stent-Graft Market
- - - Market Restraints for Peripheral Vascular Stents and AAA Stent-Graft Market
- - - Product Profiling
- - - Revenue Forecast
- - - Market Share Analysis

- 4. Regional Analysis for the Peripheral Vascular Stent and AAA Stent-Graft Market
- - Geographical Analysis of the Market
- - - German Peripheral Vascular Stent & AAA Stent-Graft Market
- - - French Peripheral Vascular Stent & AAA Stent-Graft Market
- - - The United Kingdom Peripheral Vascular Stent & AAA Stent-Graft Market
- - - Italian Peripheral Vascular Stent & AAA Stent-Graft Market
- - - Spanish Peripheral Vascular Stent & AAA Stent-Graft Market
- - - Benelux Peripheral Vascular Stent & AAA Stent-Graft Market
- - - Scandinavian Peripheral Vascular Stent & AAA Stent-Graft Market

- 5. Peripheral Vascular Stents - Procedure and Pricing and Opportunity Analysis
- - Procedures and Pricing Analysis
- - - AAA Stent-Graft Market: Graft Implants and Affected Population
- - - Peripheral Vascular Stent Procedures
- - - Peripheral Vascular Stent - Pricing Analysis
- - Opportunity Analysis
- - - Predisposing Factors of Vascular Obstructive Diseases
- - - Opportunity for Minimally Invasive Procedure
- - - Overweight and Obesity
- - - Independent Predictors of PAD
- - - Database of Key Industry Participants

- 6. Decision Support Databases
- - Supporting Data for the Study
- - - Total Healthcare Expenditure
- - - Government Healthcare Expenditure
- - - Private Healthcare Expenditure
- - - Number of Hospitals
- - - Number of Physicians

- 7. About Frost & Sullivan

Product Samples

A sample for this product is available. Please Login/Register to download this sample.

Customers who bought this item also bought